Mississippi 2023 Regular Session

Mississippi House Bill HB1370

Introduced
1/16/23  
Refer
1/16/23  

Caption

COVID-19 vaccines; require Attorney General to investigate pharmaceutical companies' promotion and distribution.

Impact

If enacted, the bill will lead to an extensive inquiry into the conduct of pharmaceutical companies in Mississippi. The investigation aims to clarify whether any crimes or deceptive practices occurred concerning vaccine advertising and promotion. It outlines various offenses that will fall under scrutiny, including misleading advertising, fraud, and RICO violations. This bill stands to reassess the trust in pharmaceutical communications, especially those that have influenced public and employment policies regarding vaccination.

Summary

House Bill 1370 mandates an investigation by the Attorney General into the activities of pharmaceutical companies in Mississippi concerning the development, promotion, and distribution of vaccines claimed to prevent COVID-19 infection, symptoms, and transmission. The bill arises from concerns regarding the truthfulness of claims made by these companies about the effectiveness and safety of COVID-19 vaccines, especially in light of instances where employees faced termination for non-compliance with vaccine mandates. The legislative findings highlight a lack of confidence among citizens regarding the information provided by pharmaceutical manufacturers, thus prompting the investigation.

Contention

The primary contention surrounding HB 1370 lies in the implications of questioning the pharmaceutical industry’s integrity and the potential chilling effect it may have on public health efforts. Proponents argue that the investigation will hold pharmaceutical companies accountable for their claims and ensure that the citizens are provided with accurate information. Critics may view this measure as an overreach, possibly endangering public trust in vaccines and health measures, which are vital for controlling the COVID-19 pandemic and ensuring community health.

Companion Bills

No companion bills found.

Previously Filed As

MS HB1515

COVID-19 vaccines; require Attorney General to investigate pharmaceutical companies' promotion and distribution.

MS HR214

Requests the attorney general to investigate whether certain corporations violated any laws in the production, distribution, or sale of COVID-19 vaccinations

MS HB2430

To create state civil liability for pharmaceutical companies for vaccine injuries from the Covid 19 vaccines

MS SB2066

District attorneys and investigators; increase annual salaries of.

MS A1472

Establishes criminal penalties for production, sale, and use of false COVID-19 vaccination verification card; requires AG to establish COVID-19 vaccination fraud prevention program.

MS A2246

Establishes criminal penalties for production, sale, and use of false COVID-19 vaccination verification card; requires AG to establish COVID-19 vaccination fraud prevention program.

MS AB327

COVID-19 vaccination status: prohibition on required disclosure.

MS HB1032

Relating to prohibited vaccination status discrimination and requirements for COVID-19 vaccines.

MS HB293

Relating to prohibited vaccination status discrimination and requirements for COVID-19 vaccines.

MS SB77

Relating to prohibited vaccination status discrimination and requirements for COVID-19 vaccines.

Similar Bills

MS HB1515

COVID-19 vaccines; require Attorney General to investigate pharmaceutical companies' promotion and distribution.

MS HB856

Pharmacy Practice Act; extend repealer on and make various changes to.

MS SB2795

Pharmacy Practice Act; extend repealer on and make various changes in.

MS SB2694

MS Pharmacy Practice Act; extend repealer on.

MS HB955

MS Pharmacy Practice Act; extend repealer on.

MS HB1119

Pharmacy benefit managers; revise provisions related to.

MS SB2677

Pharmacy Benefit Prompt Pay Act; define requirements for pharmacy benefit managers and pharmacy services administrative organizations.

MS HB1413

Pharmacy Benefit Manager Transparency Act; create.